Rituxirel 500 mg is a rituximab-based biologic medicine used for certain blood cancers and immune-mediated conditions. It works by selectively targeting B cells that contribute to abnormal cell growth or excessive immune activity, helping reduce their activity in the body. The medicine is supplied as a 50 mL vial containing 500 mg of rituximab and is administered by intravenous infusion under professional medical supervision.